Ferroptosis Biomarkers in HPV-Negative Head and Neck Squamous Cell Carcinoma
Cancers · 18.07.2026 · 18 (14) · 2320
DOI: 10.3390/cancers18142320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.07.2026. Verfasst von Sarah M Parks und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, Morgantown, WV 26506, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer of the oral cavity, pharynx, larynx and upper airway. HNSCC is subdivided into distinct clinical entities based on the presence or absence of high-risk human papillomavirus (HPV) infection. While HPV-positive HNSCC patients respond better to conventional and targeted therapies than HPV-negative cases, recurrence is more frequent in HPV-negative cases with limited treatment options. Ferroptosis is a form of iron-based programmed cell death caused by excessive lipid peroxide accumulation. Biomarkers of ferroptosis have proven useful for identifying and triggering ferroptosis in models of treatment-resistant cancers. Identifying and understanding ferroptosis biomarker function in HPV-negative HNSCC allows the possibility for more effective treatment strategies.
Methods
Literature searches combined with the public online ferroptosis database FerrDB V3 were utilized for the objective identification and classification of established and non-established ferroptosis biomarkers in HPV-negative HNSCC. Additional novel biomarkers were identified based on known roles in HNSCC oncogenesis.
Results
A total of 30 ferroptosis biomarkers were identified associated with HPV-negative disease. Biomarkers were grouped according to shared biological functions, with each marker summarized for prognostic and mechanistic roles in HNSCC ferroptosis.
Conclusions
The described biomarkers present a means for stratifying tumors for ferroptotic induction, with several offering potential novel methods for overcoming refractory HPV-negative disease. These biomarkers may warrant further investigation into devising future patient-tolerant strategies that selectively activate ferroptosis in HPV-negative HNSCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA.
- Graduate Program in Cancer Cell Biology, West Virginia University, Morgantown, WV 26506, USA.
ORCID-Profile: Werner J Geldenhuys
Förderung
- NINDS NIH HHS
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- NNational Institute of Neurological Disorders and Stroke
Zitieren
APA
Parks, S. M., Geldenhuys, W. J., & Weed, S. A. (2026). Ferroptosis Biomarkers in HPV-Negative Head and Neck Squamous Cell Carcinoma. Cancers, 18(14), 2320. https://doi.org/10.3390/cancers18142320
Vancouver
Parks SM, Geldenhuys WJ, Weed SA. Ferroptosis Biomarkers in HPV-Negative Head and Neck Squamous Cell Carcinoma. Cancers. 2026;18(14):2320. doi:10.3390/cancers18142320
BibTeX
@article{Parks2026,
author = {Parks, Sarah M and Geldenhuys, Werner J and Weed, Scott A},
title = {Ferroptosis Biomarkers in HPV-Negative Head and Neck Squamous Cell Carcinoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {14},
pages = {2320},
doi = {10.3390/cancers18142320}
}
EUVIMED